Scholars Central

Conference abstractPublished 2015

From single gene sequencing to exome sequencing: Genetic testing of rare diseases

Authors: Manuel Perez Alonso

University of Valencia Science Park, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Detecting gene mutations related to rare disease pathogenesis is a major need in patient healthcare. More than 3,000 rare diseases are known to be caused by mutations in the corresponding genes. This kind knowledge can be used for medical genetics and medical genomics, i.e., thousands of different gene tests may be developed internally in reference laboratories. Despite the obvious medical interest of this kind of genetic tests, there are only a few global labs offering more than 1,000 different gene tests in their portfolios. In this talk the professional pathway leading to the creation of the Institute of Genomic Medicine as well as the fast evolution of this reference laboratory will be described. After finding this genetics reference laboratory, in 2009, the Institute has developed into one of the main Reference Laboratories for the Genetic Testing of Rare Genetic Diseases, providing more than 6,000 gene tests per year. Only six years after establishment, the portfolio of available molecular tests from the Institute includes more than 1,300 genes corresponding to more than 1,200 rare genetic diseases. This list grows every week on demand, i.e., we accept requests from clinics or hospitals in Europe, America or Asia for new tests to be developed in our labs. Now the company includes a service for exome sequencing by Next Generation Sequencing. The key points for our development that can be summarized in (1) the creation of interdisciplinary teams between biologists, bio-informaticians and IT experts; (2) international collaboration; (3) active collaboration with the academia, small biotech companies worldwide and business people; (4) a strong commitment of the founders of the company on the idea that research has to benefit the Society; and (5) strong commitment within our team with business ethics will be described.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diagnostic Techniques and Biomedical Analysis
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Manuel Perez Alonso”